Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline versus placebo for depression in Huntington's disease
ISRCTN87426672Phase 4Recruiting
- Sponsor
- Cardiff University
- Start
- Mar 2026
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Sertraline with Placebo (2 arms). Primary endpoints: Recruitment feasibility, Retention feasibility and 2 more. Started Mar 2026; status: recruiting.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ISRCTN87426672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN87426672.